Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Cholera.

Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB.

Lancet. 2012 Jun 30;379(9835):2466-76. doi: 10.1016/S0140-6736(12)60436-X. Review.

3.

An epidemic of cholera due to Vibrio cholerae O139 in Dhaka, Bangladesh: clinical and epidemiological features.

Mahalanabis D, Faruque AS, Albert MJ, Salam MA, Hoque SS.

Epidemiol Infect. 1994 Jun;112(3):463-71.

4.

Cholera: a great global concern.

Mandal S, Mandal MD, Pal NK.

Asian Pac J Trop Med. 2011 Jul;4(7):573-80. doi: 10.1016/S1995-7645(11)60149-1. Review.

5.

Cholera.

Sack DA, Sack RB, Nair GB, Siddique AK.

Lancet. 2004 Jan 17;363(9404):223-33. Review.

PMID:
14738797
6.

[Cholera].

Fournier JM, Quilici ML.

Presse Med. 2007 Apr;36(4 Pt 2):727-39. Epub 2007 Mar 1. Review. French.

PMID:
17336031
7.

Epidemiology & molecular biology of Vibrio cholerae O139 Bengal.

Albert MJ.

Indian J Med Res. 1996 Jul;104:14-27. Review.

PMID:
8783504
8.

Association of a disease approximating cholera caused by Vibrio cholerae of serogroups other than O1 and O139.

Bhattacharya MK, Dutta D, Bhattacharya SK, Deb A, Mukhopadhyay AK, Nair GB, Shimada T, Takeda Y, Chowdhury A, Mahalanabis D.

Epidemiol Infect. 1998 Feb;120(1):1-5.

10.

Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.

Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.

Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.

PMID:
19146897
11.

Cholera - recommendations for prevention in travellers.

Neilson AA, Mayer CA.

Aust Fam Physician. 2010 Apr;39(4):220-6.

12.

Incidence of Vibrio cholerae serogroup O139 infection with low virulence in Hubli, Karnataka (India).

Krishna BV, Patil A, Nadgir SD, Chandrasekhar MR.

Indian J Pathol Microbiol. 2003 Jan;46(1):142-4.

PMID:
15027758
13.

Oral vaccines against cholera.

Shin S, Desai SN, Sah BK, Clemens JD.

Clin Infect Dis. 2011 Jun;52(11):1343-9. doi: 10.1093/cid/cir141. Epub 2011 Apr 14. Review.

PMID:
21498389
14.

Cholera in a developing megacity; Karachi, Pakistan.

Sheikh A, Khan A, Malik T, Fisher-Hoch SP.

Epidemiol Infect. 1997 Dec;119(3):287-92.

15.

[Anticholera vaccines and vaccination].

Ivanoff B, Chaignat CL.

Bull Soc Pathol Exot. 2002 Dec;95(5):355-8. Review. French.

PMID:
12696375
16.

Clinical profile of non-O1 strain-O139 of Vibrio cholerae in the region of Ambajogai, Maharashtra.

Kamble TK, More SR, Chavan SS, Kulkarni ND, Lodha NS, Kamble AS.

J Assoc Physicians India. 2000 May;48(5):505-6.

PMID:
11273144
17.

Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Bishop AL, Schild S, Patimalla B, Klein B, Camilli A.

Infect Immun. 2010 Oct;78(10):4402-20. doi: 10.1128/IAI.00398-10. Epub 2010 Aug 2.

18.

Cholera in Africa: lessons on transmission and control for Latin America.

Glass RI, Claeson M, Blake PA, Waldman RJ, Pierce NF.

Lancet. 1991 Sep 28;338(8770):791-5.

PMID:
1681168
19.

Rice-ORS versus glucose-ORS in management of severe cholera due to Vibrio cholerae O139 Bengal: a randomized, controlled clinical trial.

Hossain MS, Salam MA, Rabbani GH, Kabir I, Biswas R, Mahalanabis D.

J Health Popul Nutr. 2003 Dec;21(4):325-31.

PMID:
15038587
20.

[Cholera: recent acquisitions].

Nardiello S, Ilario A, Fusco FM, Cuomo G.

Infez Med. 2007 Jun;15(2):85-92. Review. Italian.

Supplemental Content

Support Center